Credit Suisse Continues To "See Saw" Merck's 12 Month Price Target

The call -- by Credit Suisse -- is still officially neutral. And it was just a month ago that the analysts at old CS First Boston called it at $62 -- that being up a buck, from the prior call.

But this morning, CSFB is taking that buck -- back. Y A W N. Here's the bit:

. . . .Merck saw its price target trimmed to $61 from $62 at Credit Suisse, which has the shares sitting a penny lower at $58.98. In recent weeks, the stock has been winding in the $59-$61 range, taking multiple bounces off its 120-day moving average -- currently $59.03. . . .

Not of any real moment. . . whatsoever.